ANI Pharmaceuticals | ANIP - 販売および管理費

株価
78.64
毎日の変更
0.58 0.74%
毎月
6.17%
毎年
12.63%
Q2 予測
79.14




販売および管理費 変化する 日付
AbbVie USD 3.89B 325M 2025-12
ANI Pharmaceuticals USD 82.79M 6.13M 2025-12
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Canopy Growth CAD 28.9M 636K 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Emergent BioSolutions USD 182.8M 82.3M 2023-06
Heron Therapeutics USD 23.74M 605K 2025-12
Hikma Pharmaceutical USD 288M 149M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Novartis USD 3.44B 132M 2025-12
Omeros USD 11.32M 2.48M 2024-09
Perrigo USD 255.9M 10.2M 2025-12
Sun Pharmaceuticals INR 24.89B 637.6M 2025-03
Teva Pharmaceutical Industries USD 1.12B 147M 2025-12